Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
Reck, M., von Pawel, J., Zatloukal, P., Ramlau, R., Gorbounova, V., Hirsh, V., Leighl, N., Mezger, J., Archer, V., Moore, N., Manegold, C.
Published in Annals of oncology (01.09.2010)
Published in Annals of oncology (01.09.2010)
Get full text
Journal Article
Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?
Leonard, R, O'Shaughnessy, J, Vukelja, S, Gorbounova, V, Chan-Navarro, CA, Maraninchi, D, Barak-Wigler, N, McKendrick, JJ, Harker, WG, Bexon, AS, Twelves, C
Published in Annals of oncology (01.09.2006)
Published in Annals of oncology (01.09.2006)
Get full text
Journal Article
6509 ORAL Management of hypertension (HTN) in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC) receiving first-line cisplatin and gemcitabine with bevacizumab or placebo – results from randomised phase III trial BO17704
Bennouna, J, vonPawel, J, Zatloukal, P, Ramlau, R, Gorbounova, V, Hirsh, V, Leighl, N, Mezger, J, Moore, N, Manegold, C
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
6518 ORAL Subgroup results from a randomised, double-blind, multicentre phase III study of bevacizumab in combination with cisplatingemcitabine in chemotherapy-naive patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): study BO17704
Eberhardt, W, Reck, M, vonPawel, J, Zatloukal, P, Ramlau, R, Gorbounova, V, Leighl, N, Mezger, J, Moore, N, Manegold, C
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
6570 POSTER Results for progression-free survival (PFS) from two randomised, double-blind, multicentre phase III studies of bevacizumab in combination with platin-based chemotherapy in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC) are comparable when analysed by similar populations and methodology
Sandler, A, Reck, M, vonPawel, J, Zatloukal, P, Ramlau, R, Gorbounova, V, Hirsh, V, Mezger, J, Moore, N, Manegold, C
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
6503 ORAL Efficacy and safety results from BO17704, a randomised, placebo-controlled phase III study of bevacizumab in combination with cisplatin and gemcitabine in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)
Manegold, C, vonPawel, J, Zatloukal, P, Ramlau, R, Gorbounova, V, Hirsh, V, Leighl, N, Mezger, J, Moore, N, Reck, M
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
Tolerability and efficacy of the trifunctional antibody removab® (anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/II study
Wimberger, P, Burges, A, Gorbounova, V, Sommer, H, Schmalfeldt, B, Pfisterer, J, Lichinitser, M, Makhson, A, Ströhlein, M, Eiermann, W, Biakhov, M, Moiseenko, V, Bois, A du, Kimmig, R
Published in Cancer cell international (01.07.2004)
Published in Cancer cell international (01.07.2004)
Get full text
Journal Article
1172 - Long Acting Octreotide in PTS with Disseminated Neuroendocrine Tumors
Markovich, A., Emelianova, G., Gorbounova, V., Bruzgin, V., Orel, N.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Long Acting Octreotide in PTS with Disseminated Neuroendocrine Tumors
Markovich, A., Emelianova, G., Gorbounova, V., Bruzgin, V., Orel, N.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Disrupt: A Randomized Phase 2 Trial of Ombrabulin (AVE8062) Combined with a Taxane-Platinum Regimen in the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)
von Pawel, J., Gorbounova, V., Reck, M., Kowalski, D., Allard, A., Chadjaa, M., Rey, A., Bennouna, J., Grossi, F.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Abstract S5-04: Primary results of ROSE/TRIO-12, a randomized placebo controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer
Mackey, JR, Ramos-Vazquez, M, Lipatov, O, McCarthy, N, Kraznozhon, D, Semiglazov, V, Manikhas, A, Gelmon, K, Konecny, G, Webster, M, Hegg, R, Verma, S, Gorbounova, V, Abi Gerges, D, Thireau, F, Fung, H, Simms, L, Buyse, M, Ibrahim, A, Martin, M
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Characteristics of Patients with Pleural Mesothelioma in the Russian Federation
Gorbounova, V.A, Bychkov, M.B, Vladimirova, L.Y, Levchenko, E.V, Karpenko, T.D, Mamontov, O.Y, Burmistrov, V, Novick, D, Rajan, N, Sholokhova, E, Solovyenko, Y, Tjulandin, S.A
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
DISRUPT: A randomized phase 2 trial of ombrabulin (AVE8062) combined with a taxane-platinum regimen in the first-line treatment of metastatic non-small cell lung cancer (NSCLC)
Pawel, J von, Gorbounova, V, Reck, M, Kowalski, DM, Allard, A, Chadjaa, M, Rey, A, Bennouna, J, Grossi, F
Published in Pneumologie (27.02.2013)
Published in Pneumologie (27.02.2013)
Get full text
Conference Proceeding
Gemcitabine and cisplatin double as neoadjuvant chemotherapy for operable 1B-IIIB stage NSCLC patients
Gorbounova, V., Polotsky, B., Marenich, A., Breder, V., Laktionov, K., Gerasimov, S., Dgebuadze, E., Fedenko, A., Kolesnik, A., Rodnikova, E.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Randomised, double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naïve patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): BO17704
Manegold, C., von Pawel, J., Zatloukal, P., Ramlau, R., Gorbounova, V., Hirsch, V., Leighl, N., Mezger, J., Archer, V., Reck, M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
P-452 Phase III study of docetaxel-cisplatin (DC) or docetaxel-carboplatin (DCb) versus vinorelbine-cisplatin (VC) as first-line treatment of advanced non-small cell lung cancer (NSCLC): Analyses by gender
Belani, C., von Pawel, J., Pluzanska, A., Gorbounova, V., Kaukel, E., Mattson, K., Ramlau, R., Fidias, P., Millward, M., Fossella, F.
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2005)
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2005)
Get full text
Journal Article